Search

everythinglearnresearchcommunity

for

Search:↓

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Early hair loss may indicate risk of insulin resistance.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Korean and Caucasian men with male pattern baldness have different hair steroid levels.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Treat pattern hair loss with finasteride and topical minoxidil.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Effective PCOS treatments require targeting specific signaling pathways.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.